Gils Roex

651 total citations
11 papers, 395 citations indexed

About

Gils Roex is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Gils Roex has authored 11 papers receiving a total of 395 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Molecular Biology and 4 papers in Genetics. Recurrent topics in Gils Roex's work include CAR-T cell therapy research (8 papers), Virus-based gene therapy research (4 papers) and Viral Infectious Diseases and Gene Expression in Insects (3 papers). Gils Roex is often cited by papers focused on CAR-T cell therapy research (8 papers), Virus-based gene therapy research (4 papers) and Viral Infectious Diseases and Gene Expression in Insects (3 papers). Gils Roex collaborates with scholars based in Belgium, Uganda and China. Gils Roex's co-authors include Sébastien Anguille, Diana Campillo-Davó, Zwi Berneman, Eva Lion, Yiwei Chu, Viggo Van Tendeloo, Feifei Luo, Heleen H. Van Acker, Wilfried Schroyens and Kristien Wouters and has published in prestigious journals such as Frontiers in Immunology, Cytokine & Growth Factor Reviews and Journal of Hematology & Oncology.

In The Last Decade

Gils Roex

11 papers receiving 390 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gils Roex Belgium	9	304	166	162	88	82	11	395
Sabrina Prommersberger Germany	8	381 1.3×	231 1.4×	162 1.0×	106 1.2×	92 1.1×	15	464
Vania Baldan United Kingdom	6	294 1.0×	109 0.7×	144 0.9×	40 0.5×	83 1.0×	9	360
Nawid Albinger Germany	6	279 0.9×	107 0.6×	212 1.3×	49 0.6×	39 0.5×	9	349
Vania Aikawa United States	4	291 1.0×	136 0.8×	105 0.6×	87 1.0×	68 0.8×	4	356
Julia Piasecki United States	7	260 0.9×	232 1.4×	142 0.9×	64 0.7×	41 0.5×	22	403
Elisabetta Cribioli Switzerland	9	428 1.4×	178 1.1×	231 1.4×	64 0.7×	107 1.3×	15	522
Reyisa Bughda United Kingdom	6	243 0.8×	114 0.7×	87 0.5×	40 0.5×	76 0.9×	9	313
Fengtao You China	9	575 1.9×	116 0.7×	473 2.9×	79 0.9×	69 0.8×	17	651
Silvia Arcangeli Italy	6	305 1.0×	121 0.7×	120 0.7×	40 0.5×	96 1.2×	14	331

Countries citing papers authored by Gils Roex

Since Specialization

Citations

This map shows the geographic impact of Gils Roex's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gils Roex with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gils Roex more than expected).

Fields of papers citing papers by Gils Roex

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gils Roex. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gils Roex. The network helps show where Gils Roex may publish in the future.

Co-authorship network of co-authors of Gils Roex

This figure shows the co-authorship network connecting the top 25 collaborators of Gils Roex. A scholar is included among the top collaborators of Gils Roex based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gils Roex. Gils Roex is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Roex, Gils, et al.. (2025). Expanding the CAR toolbox with high throughput screening strategies for CAR domain exploration: a comprehensive review. Journal for ImmunoTherapy of Cancer. 13(4). e010658–e010658. 1 indexed citations

Campillo-Davó, Diana, et al.. (2023). One-step CRISPR-Cas9-mediated knockout of native TCRαβ genes in human T cells using RNA electroporation. STAR Protocols. 4(1). 102112–102112. 1 indexed citations

Roex, Gils, Diana Campillo-Davó, Hans De Reu, et al.. (2022). Two for one: targeting BCMA and CD19 in B-cell malignancies with off-the-shelf dual-CAR NK-92 cells. Journal of Translational Medicine. 20(1). 124–124. 39 indexed citations

Wang, Yuedi, Bo Wang, Gils Roex, et al.. (2022). Chimeric antigen receptor clustering via cysteines enhances T-cell efficacy against tumor. Cancer Immunology Immunotherapy. 71(11). 2801–2814. 12 indexed citations

Campillo-Davó, Diana, Gils Roex, Zwi Berneman, et al.. (2021). The Ins and Outs of Messenger RNA Electroporation for Physical Gene Delivery in Immune Cell-Based Therapy. Pharmaceutics. 13(3). 396–396. 30 indexed citations

Roex, Gils, Kristien Wouters, Diana Campillo-Davó, et al.. (2020). Safety and clinical efficacy of BCMA CAR-T-cell therapy in multiple myeloma. Journal of Hematology & Oncology. 13(1). 164–164. 123 indexed citations

Roex, Gils, Tom Feys, Yves Béguin, et al.. (2020). Chimeric Antigen Receptor-T-Cell Therapy for B-Cell Hematological Malignancies: An Update of the Pivotal Clinical Trial Data. Pharmaceutics. 12(2). 194–194. 42 indexed citations

Campillo-Davó, Diana, Gils Roex, Hans De Reu, et al.. (2020). Rapid Assessment of Functional Avidity of Tumor-Specific T Cell Receptors Using an Antigen-Presenting Tumor Cell Line Electroporated with Full-Length Tumor Antigen mRNA. Cancers. 12(2). 256–256. 12 indexed citations

Roex, Gils, Yuedi Wang, Diana Campillo-Davó, et al.. (2019). Chimeric Antigen Receptor-Modified T Cell Therapy in Multiple Myeloma: Beyond B Cell Maturation Antigen. Frontiers in Immunology. 10. 67 indexed citations

10.

Acker, Heleen H. Van, Felix S. Lichtenegger, Gils Roex, et al.. (2019). Dendritic Cell-Based Immunotherapy of Acute Myeloid Leukemia. Journal of Clinical Medicine. 8(5). 579–579. 50 indexed citations

11.

Acker, Heleen H. Van, et al.. (2018). The role of the common gamma-chain family cytokines in γδ T cell-based anti-cancer immunotherapy. Cytokine & Growth Factor Reviews. 41. 54–64. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact